ArticleJournal of health & pollution2019
Polycyclic Aromatic Hydrocarbons in Ologe Lagoon and Effects of Benzo[b]fluoranthene in African Catfish.
Article in Journal of health & pollution, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.
- The occurrence and levels of polycyclic aromatic hydrocarbons (PAHs) in African environments-a systematic review.Environmental science and pollution research international · 2020Pooled it
- Environmental evaluation of PAH bioaccumulation in common sea bream (Open veterinary journal · 2026Article
- Association between polycyclic aromatic hydrocarbons exposure and metabolic dysfunction-associated steatotic liver disease in US adults.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOloge Lagoon is an important water body that receives effluents from neighboring industries. These effluents may increase the levels of anthropogenic contaminants in the lagoon, thereby creating stressors for aquatic organisms.
objectivesTo assess the occurrence of polycyclic aromatic hydrocarbons (PAHs) in Ologe Lagoon, along with the histopathological, biochemical and genotoxic effects of the most prevalent PAH compound.
methodsAn initial field study was performed to determine the concentrations of PAHs in Ologe Lagoon, followed by a chronic toxicity test to assess the effects of the most prevalent PAH compound in a fish model (Clarias gariepinus).
resultsHigh molecular weight PAHs were more predominant than low molecular weight PAHs in the lagoon, with B[b]F being the most predominant. The formation of micronuclei and binuclei was induced by a 10-fold increase over the present environmental concentration of B[b]F in Ologe Lagoon. Histopathological studies showed that epithelial necrosis, fused lamellae, shortened lamellae, and desquamation were the major histological anomalies induced by ERCs of B[b]F. Results from the biochemical assay indicated that ERCs of B[b] F increased aspartate aminotransferase and alanine transaminase levels in fish. Glutathione-S-transferase, superoxide dismutase and catalase were inhibited in the exposed fish, whereas malondialdehyde was significantly increased.
conclusionsConcentrations of fluoranthene, pyrene, benzo[a]anthracene, and benzo[a] pyrene in the surface water of Ologe Lagoon were above the Canadian Council of Ministers of the Environment's (CCME) safe limits, suggesting that the water may not be safe for domestic uses, and the present concentration of B[b]F in Ologe Lagoon may be chronically toxic to aquatic organisms, in terms of oxidative stress and hepatotoxicity. COMPETING INTERESTS: The authors declare no competing financial interests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.